Important for:

UPSC, Haryana HCS, Punjab PCS
Prelims: CAR-T therapy, immunotherapy, cancer biology
Mains: GS Paper 3 — Science & Technology, Biotechnology, Health

Why in News?

A recent scientific breakthrough has improved CAR-T cell therapy, enabling it to detect and attack solid tumours, which were previously difficult to treat using this method.

What is CAR-T Cell Therapy?

CAR-T (Chimeric Antigen Receptor T-cell) therapy is a type of:

➤ Immunotherapy — uses body’s own immune system

Process:

1. T-cells are extracted from patient
2. Genetically engineered in lab
3. Modified cells reintroduced into body
4. They attack cancer cells

What Was the Limitation Earlier?

• CAR-T therapy worked well for:
  → Blood cancers (like leukemia)
• But failed in:
  → Solid tumours

Reason:

• Tumours are heterogeneous
• Cancer cells may appear “invisible” to immune cells

What is the New Breakthrough?

Key Innovation:

• New receptor detects very small protein signals
• Even low antigen levels can now trigger immune response

➤ Earlier:

• Only high antigen levels were detectable

➤ Now:

• Even “faint targets” can be identified

How It Works

• Tumour cells have proteins (antigens)
• Earlier CAR-T:
  → Ignored weak signals
• New CAR-T:
  → Detects even minimal protein presence
  → Activates immune attack

Why This Matters

Medical Impact:

• Expands CAR-T use beyond blood cancers
• Opens treatment for:
  • Solid tumours
  • Hard-to-detect cancers

Scientific Impact:

• Breakthrough in:
  → Precision medicine
  → Immunotherapy

Challenges Still Remain

• Safety concerns (overactivation of immune system)
• High cost of treatment
• Complex manufacturing process
• Clinical trials still ongoing

India Context

• Growing biotech sector
• Increasing cancer burden
• Need for:
  • Affordable advanced therapies
  • Research & innovation

PRELIMS PRACTICE QUESTIONS

Q1. CAR-T therapy is related to:

A. Vaccination
B. Immunotherapy
C. Radiation therapy
D. Chemotherapy

✅ Answer: B

Q2. CAR-T cells are derived from:

A. B-cells
B. Red blood cells
C. T-cells
D. Platelets

✅ Answer: C

Q3. Which of the following is correct?

1. CAR-T therapy uses genetically modified cells
2. It is effective only for viral diseases
3. It can treat cancer

A. 1 and 3 only
B. 2 only
C. 1 only
D. 1, 2 and 3

✅ Answer: A

Q4. Solid tumours were difficult to treat because:

A. Lack of blood supply
B. Low antigen visibility
C. High oxygen levels
D. Absence of immune cells

✅ Answer: B

Q5. Immunotherapy works by:

A. Killing all cells in body
B. Boosting immune response
C. Reducing oxygen supply
D. Blocking blood flow

✅ Answer: B

Q6. Which of the following is NOT a challenge of CAR-T therapy?

A. High cost
B. Safety risks
C. Easy mass production
D. Complex procedure

✅ Answer: C

CBL Mains Practice Question

“Advancements in immunotherapy are transforming cancer treatment but remain inaccessible to many.”
Discuss in the context of recent developments in CAR-T cell therapy. (250 words)

FAQs

1. What is CAR-T cell therapy?

A treatment where immune cells are engineered to attack cancer cells.

2. Why was CAR-T limited earlier?

It could not detect weak signals from solid tumours.

3. What is the new breakthrough?

Detection of very low antigen levels in tumour cells.

4. Why is this important?

It expands cancer treatment to solid tumours.

5. Which GS paper covers this topic?

GS Paper 3 — Science & Technology.